Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
AKTS on Nasdaq
There are no Buy or Sell transactions made by Lloyd Mitchell Segal since 07 Mar 2025
Holdings reported by Lloyd Mitchell Segal for Aktis Oncology, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
19,631 |
|
|
12 Jan 2026 |
Indirect |
|
|
| Series A Redeemable Convertible Preferred Stock |
0 |
|
|
12 Jan 2026 |
Indirect |
Common Stock |
|
| Series B Redeemable Convertible Preferred Stock |
0 |
|
|
12 Jan 2026 |
Indirect |
Common Stock |
|
Transactions reported by Lloyd Mitchell Segal for Aktis Oncology, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.